Abstract
Hematopoietic stem cell transplantation (HSCT) has been used for a variety of malignant and nonmalignant diseases of the blood and immune-system in adults, children, and even infants. The HSCT involves the ablation of the bone marrow of the recipient with high doses of chemotherapy, and in some cases also radiation, to allow engraftment of the donor cells. It is autologous when the cells are from the own patient and allogeneic when the cells comes from a donor. The ability to successfully transplant hematopoietic stem cells to reconstitute the hematopoietic system is a relatively new area and in constant development [34, 91].
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Dessels C, Alessandrini M, Pepper MS. Factors influencing the umbilical cord blood stem cell industry: an evolving treatment landscape. Stem Cells Transl Med. 2018;7(9):643–50. https://stemcellsjournals.onlinelibrary.wiley.com/doi/full/10.1002/sctm.17-0244 (Aug 13, 2019).
Hastings CA, Torkildson JC, Agrawal AK. Handbook of pediatric hematology and oncology: children’s Hospital & Research Center Oakland. 2nd ed. New York: Wiley Blackwell; 2013.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Schmidt, C.W.P. (2020). The Pharmacist in Pediatric Hematopoietic Stem Cell Transplantation. In: Pediatric Hematopoietic Stem Cell Transplantation for Pharmacists. Springer, Cham. https://doi.org/10.1007/978-3-030-43491-5_1
Download citation
DOI: https://doi.org/10.1007/978-3-030-43491-5_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-43490-8
Online ISBN: 978-3-030-43491-5
eBook Packages: MedicineMedicine (R0)